Solid Biosciences Inc. SLDB Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s free cash flow?
- Solid Biosciences Inc. (SLDB) reported free cash flow of -$47.4M in Q1 2026.
- How has Solid Biosciences Inc.'s free cash flow changed year-over-year?
- Solid Biosciences Inc.'s free cash flow decreased by 48.2% year-over-year, from -$31.98M to -$47.4M.
- What is the long-term trend for Solid Biosciences Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s free cash flow has grown at a 18.8% compound annual growth rate (CAGR), from -$79.05M to -$157.44M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.